Page last updated: 2024-10-20

pyrazole and Auricular Fibrillation

pyrazole has been researched along with Auricular Fibrillation in 1 studies

1H-pyrazole : The 1H-tautomer of pyrazole.

Research Excerpts

ExcerptRelevanceReference
" This compound also showed good bioavailability in rats and robust pharmacodynamic effects in a rabbit model."1.35Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists. ( Atwal, K; Bhandaru, R; Conder, M; Finlay, HJ; Huang, CS; Huynh, T; Jenkins-West, T; Kover, A; Levesque, P; Li, D; Lloyd, J; Prol, J; Sun, H; Vaccaro, W; Yan, L, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lloyd, J1
Finlay, HJ1
Atwal, K1
Kover, A1
Prol, J1
Yan, L1
Bhandaru, R1
Vaccaro, W1
Huynh, T1
Huang, CS1
Conder, M1
Jenkins-West, T1
Sun, H1
Li, D1
Levesque, P1

Other Studies

1 other study available for pyrazole and Auricular Fibrillation

ArticleYear
Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists.
    Bioorganic & medicinal chemistry letters, 2009, Sep-15, Volume: 19, Issue:18

    Topics: Animals; Atrial Fibrillation; Cell Line; Humans; Kv1.5 Potassium Channel; Mice; Potassium Channel Bl

2009